Evidence map›Paper›PMID 35701103›Full record

ArticleJournal of medical genetics2022

The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness.

David Hessl, Hilary Rosselot, Robert Miller, Glenda Espinal, Jessica Famula, Stephanie L Sherman, Peter K Todd, Ana Maria Cabal Herrera, Karen Lipworth, Jonathan Cohen and 9 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

David HesslDepartment of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California, USA drhessl@ucdavis.edu.ORCID 0000-0002-3460-9805
Hilary RosselotNational Fragile X Foundation, McLean, Virginia, USA.
Robert MillerNational Fragile X Foundation, McLean, Virginia, USA.
Glenda EspinalDepartment of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California, USA.
Jessica FamulaDepartment of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California, USA.
Stephanie L ShermanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
Peter K ToddDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Ana Maria Cabal HerreraUniversidad del Valle School of Medicine, Cali, Colombia.ORCID 0000-0002-4879-4896
Karen LipworthFragile X Association of Australia, Brookvale, New South Wales, Australia.
Jonathan CohenGenetic Clinics Australia, Victoria, Melbourne, Australia.
Deborah A HallDepartment of Neurological Sciences, Rush University, Chicago, Illinois, USA.
Maureen LeeheyDepartment of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jim GrigsbyDepartment of Psychology, University of Colorado Denver, Denver, Colorado, USA.
Jayne Dixon WeberNational Fragile X Foundation, McLean, Virginia, USA.
Sundus AlusiWalton Centre, Liverpool, UK.
Anne WheelerRTI International, Research Triangle Park, North Carolina, USA.
Melissa RaspaRTI International, Research Triangle Park, North Carolina, USA.
Tamaro HudsonDepartment of Pharmacology, Howard University College of Medicine, Washington, District of Columbia, USA.
Sonya K SobrianDepartment of Pharmacology, Howard University College of Medicine, Washington, District of Columbia, USA.
National Fragile X Foundation · USUniversity of California Davis Medical Center · USHoward University · USRTI International · USUniversity of Colorado Denver · USEmory University · USRush University · USUniversidad del Valle · COUniversity of Liverpool · GBUniversity of Michigan · US

Funding

CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity SupplementR01NS086810 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2014 to 2024
$4.1M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fragile X Messenger Ribonucleoprotein 1Neurodegenerative DiseasesGuanineHumansRegistriesTrinucleotide Repeat ExpansionFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Guaninemovement disordersneurodegenerative diseasespsychiatryreproductive healthwomen's health

Identifiers

PMID35701103
PMCPMC9691813
OpenAlexW4282922397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.